Hyperbaric Oxygen for Hospitalized patients with Ulcerative Colitis

Area of Science:

• Gastroenterology and Hepatology
• Regenerative Medicine

Background:

• Severe acute exacerbations of ulcerative colitis (UC) affect 25% of patients.
• High-dose corticosteroids fail in 50% of severe UC cases, often leading to colectomy.
• Urgent colectomy is a common outcome for medically refractory severe UC.

Discussion:

• A double-blind, sham-controlled trial investigated hyperbaric oxygen therapy (HBOT) for severe UC.
• HBOT administration at presentation rapidly induced short-term remission.
• This approach potentially avoids the need for second-line medical rescue therapy.

Key Insights:

• Short-term HBOT shows promise in managing severe ulcerative colitis flares.
• Early intervention with HBOT may alter the disease trajectory for UC patients.
• This proof-of-concept study highlights a novel therapeutic avenue for UC.

Outlook:

• Further dose-finding studies for HBOT in UC are currently in progress.
• HBOT could represent a new non-invasive treatment option for severe ulcerative colitis.
• Investigating long-term efficacy and optimal HBOT protocols is essential.